R. Smith

发表

17β-Estradiol-mediated growth inhibition of MDA-MB-468 cells stably transfected with the estrogen receptor: Cell cycle effects

S. Safe, R. Burghardt, Weili Wang, 1997, Molecular and Cellular Endocrinology.

1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways

S. Safe, A. Frankel, Shaheen Khan, 2008, Breast Cancer Research and Treatment.

Role of estrogen receptor (ER) α in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells

S. Safe, R. Burghardt, R. Smith, 2005 .

Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG 2 Cancer Cells

M. Abdelrahim, R. Smith, 2003 .

ASN004, A 5T4-targeting scFv-Fc Antibody–Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models

N. Damle, H. Usansky, Sanjeeva P. Reddy, 2021, Molecular Cancer Therapeutics.

A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes

S. Safe, M. Abdelrahim, I. Samudio, 2004, Molecular Cancer Therapeutics.

Curcumin decreases specificity protein expression in bladder cancer cells.

S. Safe, I. Jutooru, G. Chadalapaka, 2008, Cancer research.

Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells

M. Abdelrahim, R. Burghardt, Maen Abdelrahim, 2004, Cancer Research.

Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

Stephen Safe, S. Safe, M. Abdelrahim, 2003, Molecular pharmacology.

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors

V. Seshan, E. de Stanchina, A. Younes, 2021, Cell reports. Medicine.

Interferon‐inhibited human osteosarcoma xenografts induce host bone in nude mice

H. Bauer, J. Triffitt, O. Nilsson, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Peroxisome Proliferator-activated Receptor γ Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor α in MCF-7 Breast Cancer Cells

S. Safe, R. Burghardt, M. Wormke, 2003 .

in MCF-7 Breast Cancer Cells α Estrogen Receptor andInduce Proteasome-dependent Degradation of Cyclin D 1 Agonists γ Peroxisome Proliferator-activated Receptor Updated

S. Safe, R. Burghardt, M. Wormke, 2003 .

Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.

S. Safe, R. Burghardt, M. Wormke, 2003, Cancer research.

A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.

M. Abdelrahim, I. Samudio, T. Phillips, 2004, Molecular Cancer Therapeutics.

WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity.

Hongjun Jin, P. LiWang, R. Smith, 2008, Antimicrobial agents and chemotherapy.